Drug intelligence / Profile preview

Vaxol Baby öronspray

Development stage: Unknown
Lead developer: Farmacia Nordic
Administration: Otic

Overview

Vaxol Baby öronspray is a pediatric ear spray developed and distributed by Farmacia Nordic AB for earwax removal and ear cleaning in children from 6 months of age. It is a non-pharmacological medical device composed of 80% pharmaceutically purified olive oil and mineral oil. The formulation works by softening and dissolving earwax in harmony with the ear's natural self-cleaning mechanism, while also creating a protective barrier in the ear canal to shield against water and dirt. It is free from fragrances and colorants to minimize irritation in sensitive pediatric ear canals and is approved under the EU Medical Device Regulation (MDR).

Brand names: Vaxol Baby öronsprayVaxol Baby
Other names: Vaxol Baby ear spray

Beyond the preview

Go deeper on Vaxol Baby öronspray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaxol Baby öronspray.

Explore the full profile